Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 25% ± 9% | |
brain | 9 studies | 33% ± 15% | |
peripheral blood | 6 studies | 25% ± 7% | |
intestine | 5 studies | 20% ± 6% | |
liver | 5 studies | 33% ± 16% | |
uterus | 4 studies | 27% ± 15% | |
prostate | 4 studies | 27% ± 9% | |
adipose | 4 studies | 17% ± 1% | |
pancreas | 3 studies | 38% ± 11% | |
eye | 3 studies | 27% ± 11% | |
breast | 3 studies | 28% ± 9% | |
bone marrow | 3 studies | 19% ± 3% | |
kidney | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6924.92 | 459 / 459 | 100% | 108.61 | 1118 / 1118 |
esophagus | 100% | 7302.66 | 1445 / 1445 | 100% | 80.23 | 183 / 183 |
intestine | 100% | 7308.73 | 966 / 966 | 100% | 78.28 | 527 / 527 |
lung | 100% | 7452.52 | 578 / 578 | 100% | 70.33 | 1155 / 1155 |
ovary | 100% | 5427.33 | 180 / 180 | 100% | 55.92 | 430 / 430 |
pancreas | 100% | 5110.81 | 328 / 328 | 100% | 50.70 | 178 / 178 |
prostate | 100% | 7116.58 | 245 / 245 | 100% | 82.07 | 502 / 502 |
stomach | 100% | 6459.41 | 359 / 359 | 100% | 74.59 | 286 / 286 |
bladder | 100% | 7058.62 | 21 / 21 | 100% | 66.30 | 503 / 504 |
uterus | 100% | 5451.73 | 170 / 170 | 100% | 66.01 | 458 / 459 |
brain | 100% | 4260.01 | 2629 / 2642 | 100% | 63.67 | 705 / 705 |
skin | 100% | 7929.04 | 1809 / 1809 | 99% | 62.36 | 469 / 472 |
thymus | 100% | 6475.90 | 653 / 653 | 99% | 52.74 | 601 / 605 |
kidney | 100% | 5617.84 | 89 / 89 | 99% | 46.24 | 893 / 901 |
liver | 100% | 4136.88 | 226 / 226 | 96% | 30.87 | 391 / 406 |
adrenal gland | 100% | 8957.99 | 258 / 258 | 93% | 33.94 | 213 / 230 |
adipose | 100% | 7223.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6030.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.32 | 29 / 29 |
muscle | 100% | 11959.01 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 7183.97 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6201.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.98 | 1 / 1 |
heart | 96% | 5205.41 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 34.90 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006412 | Biological process | translation |
GO_0006479 | Biological process | protein methylation |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0006415 | Biological process | translational termination |
GO_0006449 | Biological process | regulation of translational termination |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0018444 | Cellular component | translation release factor complex |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005525 | Molecular function | GTP binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003747 | Molecular function | translation release factor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | GSPT1 |
Protein name | G1 to S phase transition 1 Eukaryotic peptide chain release factor GTP-binding subunit (ERF2) (Polypeptide release factor 3) (Translation release factor 3) Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog) |
Synonyms | ERF3A |
Description | FUNCTION: GTPase component of the eRF1-eRF3-GTP ternary complex, a ternary complex that mediates translation termination in response to the termination codons UAA, UAG and UGA . GSPT1/ERF3A mediates ETF1/ERF1 delivery to stop codons: The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site . GTP hydrolysis by GSPT1/ERF3A induces a conformational change that leads to its dissociation, permitting ETF1/ERF1 to accommodate fully in the A-site . Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons . Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes . . |
Accessions | ENST00000563468.5 [P15170-1] ENST00000562169.1 H3BMT9 H3BSV8 H3BR35 ENST00000420576.6 [P15170-1] ENST00000565267.5 ENST00000434724.7 [P15170-3] ENST00000439887.6 [P15170-2] P15170 ENST00000568849.5 |